[144] IREN Limited SEC Filing

Rhea-AI Filing Summary

IREN Limited filed a Form 144 notifying the proposed sale of 1,000,000 ordinary shares through B. Riley Securities on NASDAQ, scheduled approximately for 09/11/2025. The filing lists an aggregate market value of $33,131,000 and reports 274,282,163 shares outstanding. Acquisition details show portions of the shares were originally received from the issuer as subscriber shares on 11/06/2018 (490,732 shares) and from restricted stock unit vestings on 06/19/2023 (237,722 shares) and 07/01/2023 (271,546 shares), with payments characterized as cash or remuneration. The filing also discloses two option-related sales by Awassi Capital entities on 09/03/2025 and 09/04/2025 totaling 1,000,000 option shares that generated gross proceeds of about $24.5 million. The filer certifies no undisclosed material adverse information.

Positive

• Transparent disclosure of the source and acquisition dates for the shares (subscriber shares and vested RSUs)
• Use of a recognized broker (B. Riley Securities) and specification of an approximate sale date supports orderly market execution
• Filer certification that no undisclosed material adverse information is known

Negative

• Insider liquidity events including the proposed 1,000,000-share sale and recent option-related sales could increase near-term supply
• Aggregate market value of $33.13 million for the proposed sale is sizable and could have short-term market impact despite modest share percentage

Insights

Securities Analyst

TL;DR Proposed sale of 1,000,000 IREN shares (~0.36% of shares outstanding) is disclosed; prior related option sales totaled ~1,000,000 shares.

From a trading and disclosure perspective this Form 144 is routine: it notifies a planned sale through a broker, identifies the acquisition sources (subscriber shares and vested RSUs), and quantifies the aggregate market value. The planned sale size relative to outstanding shares is modest, suggesting limited dilution pressure, though the $33.1 million market value could be meaningful to short-term supply-demand dynamics. Recent option exercises and sales by Awassi Capital indicate concurrent insider-related liquidity events that could increase near-term supply.

Corporate Governance Expert

TL;DR Filing provides standard attestations and provenance of shares; no governance red flags are evident from the notice alone.

The form includes the required signature representations and confirms the seller does not possess undisclosed material adverse information. The provenance entries (subscriber shares and RSU vestings) are clearly disclosed, which supports transparency around insider sales. There is no indication of unusual related-party arrangements or undisclosed compensation mechanisms within this notice. Material governance assessments would require additional context beyond this Form 144.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	B. Riley Securities, Inc. 11100 Santa Monica Blvd. Suite 800 Los Angeles CA 90025	1000000	33131000.00	274282163	09/11/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	11/06/2018	Received directly from the issuer as subscriber shares	Issuer			490732	11/06/2018	Cash
Ordinary Shares	06/19/2023	Restricted stock units vested on July 1, 2024	Issuer			237722	06/19/2023	Remuneration
Ordinary Shares	07/01/2023	Restricted stock units vested on July 1, 2024	Issuer			271546	07/01/2023	Remuneration

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Awassi Capital Holdings 1 Pty Ltd., ATF Awassi Capital Trust #1 Level 6 55 Market Street Sydney C3 NSW 2000	Options to purchase ordinary shares expiring December 20, 2025	09/03/2025	500000	12757336.45
Awassi Capital Holdings 1 Pty Ltd., ATF Awassi Capital Trust #1 Level 6 55 Market Street Sydney C3 NSW 2000	Options to purchase ordinary shares expiring December 20, 2025	09/04/2025	500000	11765987.03

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does IREN's Form 144 disclose about the number of shares to be sold?

The filing notifies a proposed sale of 1,000,000 ordinary shares through B. Riley Securities, with an approximate sale date of 09/11/2025.

How much is the aggregate market value for the shares in the IREN Form 144?

The aggregate market value reported in the filing is $33,131,000 for the 1,000,000 shares.

What is the company share count reported in the filing?

The filing lists 274,282,163 shares outstanding for IREN.

Were any related share sales disclosed recently for IREN?

Yes; the filing discloses two option-related sales by Awassi Capital entities on 09/03/2025 and 09/04/2025 totaling 1,000,000 option shares with combined gross proceeds of about $24.5 million.

What were the acquisition sources for the shares to be sold?

The shares were acquired as subscriber shares on 11/06/2018 (490,732 shares) and from RSU vestings on 06/19/2023 and 07/01/2023 (237,722 and 271,546 shares respectively).